The current valuation score of HCW Biologics Inc is 8.94, ranking 72 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.14, which is -86.27% below the recent high of -0.02 and -191140.27% above the recent low of -267.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.